Anticancer platinum-drug delivered by mesenchymal stromal cells improves its activity on glioblastoma

Anticancer platinum-drug delivered by mesenchymal stromal cells improves its activity on glioblastoma

Abstract Background Glioblastoma multiforme (GBM) is nowadays the most aggressive tumor affecting brain in adults with a very poor prognosis due to the limited therapies and the systemic cytotoxicity. Among the different new drugs, recently has been reported the in vitro anti-glioma activity of a ne...

Full description

Bibliographic Details
Main Authors: Valentina Coccè, Eleonora Martegani, Luisa Doneda, Isabella Rimoldi, Giorgio Facchetti, Coffetti Giulia, Giorgio Lucchini, Leda Roncoroni, Aldo Giannì, Costantino Corradini, Giulio Alessandri, Emilio Ciusani, Francesco Cilurzo, Silvia Franzè, Francesca Paino, Augusto Pessina
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cancer Nanotechnology
Subjects:
Mesenchymal stromal cells
Drug delivery
Extracellular vesicles
Platinum drugs
Spheroids
Glioblastoma
Online Access:https://doi.org/10.1186/s12645-023-00242-2

Internet

https://doi.org/10.1186/s12645-023-00242-2

Similar Items